KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Gains from Sales and Divestitures (2018 - 2019)

Historic Gains from Sales and Divestitures for NovoCure (NVCR) over the last 2 years, with Q2 2019 value amounting to $723554.0.

  • NovoCure's Gains from Sales and Divestitures rose 3145.54% to $723554.0 in Q2 2019 from the same period last year, while for Jun 2019 it was $723554.0, marking a year-over-year increase of 3145.54%. This contributed to the annual value of $556563.0 for FY2018, which is N/A changed from last year.
  • As of Q2 2019, NovoCure's Gains from Sales and Divestitures stood at $723554.0, which was up 3145.54% from $391191.0 recorded in Q1 2019.
  • Over the past 5 years, NovoCure's Gains from Sales and Divestitures peaked at $723554.0 during Q2 2019, and registered a low of $256578.0 during Q1 2018.